Application no. and date | 18726972.5 (espacenet) (Federated) (European Patent Register), 20180523 | Patent/reg. no. and date | DK/EP 3630793, 20240710 | Publication date | 20200408 | Priority no. and date | GB 201708277, 20170524 | EP pub. no. and date |
EP 3630793 20200408 | Effective date | | Applicant/owner | Cytiva BioProcess R&D AB, Björkgatan 30
751 84 Uppsala, SE | Applicant ref. no. | P84948DK01 | Inventor | RODRIGO, Gustav, GE Healthcare Björkgatan 30
751 84 Uppsala, SE, BJORKMAN, Tomas, GE Healthcare Björkgatan 30
751 84 Uppsala, SE, ANDER, Mats, GE Healthcare Björkgatan 30
751 84 Uppsala, SE, BERGMAN, Magnus, GE Healthcare Bjorkgatan 30
751 84 Uppsala, SE, GALLI, Joakim, GE Healthcare Bjorkgatan 30
751 84 Uppsala, SE | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | C07K 1/16 (2006.01) , C07K 1/22 (2006.01) , C07K 14/31 (2006.01) , C07K 14/315 (2006.01) , C07K 14/33 (2006.01) , C07K 16/00 (2006.01) , C07K 17/00 (2006.01) , C07K 7/08 (2006.01) , C12N 15/62 (2006.01) | Title | REKOMBINANT PROTEIN | Int. application no. | EP2018063435 | Int. publication no. | WO2018215503 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|